NCT03821272 2025-10-08A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer PatientsUniversity of ArkansasPhase 1/2 Completed17 enrolled 30 charts
NCT05952934 2025-05-15Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce RecurrenceUniversity of ArkansasPhase 2 Recruiting100 enrolled